Detection of human papilloma virus type 16 E6 mRNA in laryngeal squamous cell carcinoma by in situ hybridization
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Laryngeal squamous cell carcinoma (LSCC) is a common malignant tumor in Northeast China and is frequently associated with well-established risk factors like smoking and alcohol abuse. Human papilloma virus (HPV) is an epitheliotropic oncogenic virus that has been detected in a variety of head and neck tumors including LSCC. This retrospective study was to investigate the prevalence of HPV infection in patients with LSCC.
In situ hybridization was performed in 99 patients with LSCC to detect the expression of HPV-16 E6 mRNA.
The positive rate of HPV16 E6 mRNA was 36.36% (36/99) in laryngeal squamous cell carcinoma (LSCC), whereas only 3 of 50 (6%) specimens of the normal laryngeal mucosa as a control group showed positive results (P<0.05).Additionally, there was no corelation between HPV16 and age, gender, clinical stage, nodal status and tumor site (P>0.05).
The results suggest that the increased prevalence of HPV infection compared to normal laryngeal mucosa and the fact that high-risk HPV types (especially type 16) were the most frequently identified do not allow the exclusion of HPV as a risk factor in laryngeal squamous cell carcinoma. However, their clinical value remains to be further investigated.
- Detection of human papilloma virus type 16 E6 mRNA in laryngeal squamous cell carcinoma by in situ hybridization
Chinese Journal of Cancer Research
Volume 22, Issue 3 , pp 218-223
- Cover Date
- Print ISSN
- Online ISSN
- Chinese Anti-Cancer Association
- Additional Links
- Laryngeal squamous cell carcinoma
- Human papilloma virus
- In situ hybridization
- Author Affiliations
- 1. Department of Clinical Laboratory, Chongqing Medical University, Chongqing, 630001, China
- 2. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Head and Neck Surgery, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, 100142, China
- 3. Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Genetics, Peking University School of Oncology, Beijing Cancer Hospital & Institute, Beijing, 100142, China
- 4. Department of Pathology, Peking University Shougang Hospital, Beijing, 100144, China